Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4457951000168117 | Qarziba (dinutuximab beta 20 mg / 4.5 mL) injection, 4.5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4457961000168115 | Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | Is a | Qarziba | true | Inferred relationship | Some | ||
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | Is a | dinutuximab beta 20 mg/4.5 mL injection, vial | true | Inferred relationship | Some | ||
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | has unit of use | vial | true | Inferred relationship | Some | 129967741 | |
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | has Australian BoSS | dinutuximab beta | true | Inferred relationship | Some | 1695499535 | |
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | has intended active ingredient | dinutuximab beta | true | Inferred relationship | Some | 1695499535 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | has TPUU | True | Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | Inferred relationship | Some | 2010943045 |
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | has TPUU | True | Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | Inferred relationship | Some | 2097599748 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR